Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Taflin

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The British Journal of Surgery|March 4, 2026
Post-hepatectomy liver failureKjetil Soreide, Anita Balakrishnan, Helena Taflin
Cancer Chemotherapy and Pharmacology|September 21, 2014
Folate levels measured by LC-MS/MS in patients with colorectal cancer treated with different leucovorin dosagesHelena Taflin, Yvonne Wettergren, Elisabeth Odin, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2009
Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancerKristoffer Derwinger, Karl Kodeda, Elinor Bexe-Lindskog, et al.
Anticancer Research|August 27, 2011
Gene polymorphisms MTHFRC677T and MTRA2756G as predictive factors in adjuvant chemotherapy for stage III colorectal cancerHelena Taflin, Yvonne Wettergren, Elisabeth Odin, et al.
Cancer Chemotherapy and Pharmacology|October 25, 2014
A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized studyYvonne Wettergren, Helena Taflin, Elisabeth Odin, et al.
Clinical Medicine Insights. Oncology|March 6, 2014
Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal CancerHelena Taflin, Yvonne Wettergren, Elisabeth Odin, et al.
World Journal of Surgical Oncology|September 2, 2022
Prolonged postoperative length of stay may be a valuable marker for susceptibility to relapse beyond established risk factors in patients with stage III colon cancerFrans Emland, Helena Taflin, Göran Carlsson, et al.
Trials|September 30, 2022
SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment-a randomized controlled multicenter trialVeronica Reivell, Helga Hagman, Johan Haux, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2020
Surgical treatment of breast cancer liver metastases - A nationwide registry-based case control studyMarcus Sundén, Cecilia Hermansson, Helena Taflin, et al.
Cancer Chemotherapy and Pharmacology|October 25, 2020
Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorinHelena Taflin, Elisabeth Odin, Göran Carlsson, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The British Journal of Surgery|March 4, 2026
Post-hepatectomy liver failureKjetil Soreide, Anita Balakrishnan, Helena Taflin
Cancer Chemotherapy and Pharmacology|September 21, 2014
Folate levels measured by LC-MS/MS in patients with colorectal cancer treated with different leucovorin dosagesHelena Taflin, Yvonne Wettergren, Elisabeth Odin, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2009
Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancerKristoffer Derwinger, Karl Kodeda, Elinor Bexe-Lindskog, et al.
Anticancer Research|August 27, 2011
Gene polymorphisms MTHFRC677T and MTRA2756G as predictive factors in adjuvant chemotherapy for stage III colorectal cancerHelena Taflin, Yvonne Wettergren, Elisabeth Odin, et al.
Cancer Chemotherapy and Pharmacology|October 25, 2014
A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized studyYvonne Wettergren, Helena Taflin, Elisabeth Odin, et al.
Clinical Medicine Insights. Oncology|March 6, 2014
Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal CancerHelena Taflin, Yvonne Wettergren, Elisabeth Odin, et al.
World Journal of Surgical Oncology|September 2, 2022
Prolonged postoperative length of stay may be a valuable marker for susceptibility to relapse beyond established risk factors in patients with stage III colon cancerFrans Emland, Helena Taflin, Göran Carlsson, et al.
Trials|September 30, 2022
SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment-a randomized controlled multicenter trialVeronica Reivell, Helga Hagman, Johan Haux, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2020
Surgical treatment of breast cancer liver metastases - A nationwide registry-based case control studyMarcus Sundén, Cecilia Hermansson, Helena Taflin, et al.
Cancer Chemotherapy and Pharmacology|October 25, 2020
Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorinHelena Taflin, Elisabeth Odin, Göran Carlsson, et al.
Pageof 3